市場調査レポート

商品コード

1701073

内視鏡的逆行性胆管膵管造影の市場規模、シェア、成長分析、製品タイプ別、手技別、エンドユーザー別、地域別-2025～2032年産業予測

Endoscopic Retrograde Cholangiopancreatography Market Size, Share, and Growth Analysis, By Product Type (Endoscopes, Endotherapy Devices), By Procedure (Biliary Sphincterotomy, Biliary Stenting), By End Users, By Region - Industry Forecast 2025-2032

出版日: 2025年04月02日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 767,811円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 898,194円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,028,577円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.87円

全表示
概要
目次

概要

サンプル依頼リストに入れる

内視鏡的逆行性胆管膵管造影の世界市場規模は、2023年に15億米ドルと評価され、2024年の16億5,000万米ドルから2032年には34億8,000万米ドルに成長し、予測期間（2025～2032年）のCAGRは9.8％で成長する展望です。

低侵襲手術手技の人気の高まりは、内視鏡的逆行性胆管膵管造影（ERCP）手技の需要の大幅な上昇につながり、このセグメントは今後数年で力強い成長を遂げると位置づけられています。ERCPが好まれる背景には、従来の手術に比べて回復期間が短く、合併症の発生率が低いといった利点があります。米国では2023年に約4万1210人の肝臓がん患者が新たに発生すると予測されており、米国がん協会が発表した最近のデータは、こうした進歩の緊急性を浮き彫りにしています。この統計は、洗練された診断・治療オプションの必要性が高まっていることを強調しており、ERCP市場における継続的な投資と技術革新の重要性を強調しています。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他の欧州
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主要市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022～2024年）
  主要企業プロファイル
  - Olympus Corporation（日本）
  - CONMED Corporation（米国）
  - Fujifilm Holdings Corporation（日本）
  - HOYA Corporation（日本）
  - Boston Scientific Corporation（米国）
  - Johnson & Johnson（米国）
  - Medtronic PLC（アイルランド）
  - Cook Medical（米国）
  - STERRIS PLC（米国）
  - TeleMed Systems Inc.（米国）
  - DCC Healthcare（Medi-Globe GmbH）（アイルランド）
  - Huger Medical Instrument Co. Ltd（中国）
  - SonoScape Medical Corporation（中国）
  - KARL STORZ SE & Co. KG（ドイツ）
  - Ambu A/S（デンマーク）
  - B. Braun Melsungen AG（ドイツ）
  - PENTAX Medical（日本）
  - Hitachi Ltd.（日本）
  - Canon Medical Systems Corporation（日本）
  - Sony Corporation（日本）

結論と提言

Product Code: SQMIG35A2748

Global Endoscopic Retrograde Cholangiopancreatography Market size was valued at USD 1.5 billion in 2023 and is poised to grow from USD 1.65 billion in 2024 to USD 3.48 billion by 2032, growing at a CAGR of 9.8% during the forecast period (2025-2032).

The rising popularity of minimally invasive surgical techniques has led to a significant uptick in the demand for endoscopic retrograde cholangiopancreatography (ERCP) procedures, positioning this sector for robust growth in the coming years. The preference for ERCP is driven by its benefits, such as shorter recovery periods and decreased complication rates compared to traditional surgery. Recent data from the American Cancer Society highlights the urgency for such advancements, as the U.S. anticipates approximately 41,210 new liver cancer cases in 2023. This statistic underlines the increasing necessity for sophisticated diagnostic and therapeutic options, reinforcing the importance of ongoing investments and innovations within the ERCP market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Endoscopic Retrograde Cholangiopancreatography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Endoscopic Retrograde Cholangiopancreatography Market Segments Analysis

Global Endoscopic Retrograde Cholangiopancreatography Market is segmented by Product Type, Procedure, End Users and region. Based on Product Type, the market is segmented into Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices and Others. Based on Procedure, the market is segmented into Biliary Sphincterotomy, Biliary Stenting, Biliary Dialtation, Pancreatic Sphincterotomy, Pancreatic Duct Stenting and Pancreatic Duct Dilatation. Based on End Users, the market is segmented into Hospitals, Ambulatory Surgery Centers & Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Endoscopic Retrograde Cholangiopancreatography Market

The global endoscopic retrograde cholangiopancreatography (ERCP) market is propelled by the increasing demand for advanced diagnostic and therapeutic solutions targeting the pancreas, liver, gallbladder, and bile ducts. ERCP is a sophisticated procedure that combines luminal endoscopy and fluoroscopic imaging, allowing for effective identification and treatment of pancreatobiliary disorders. This technique involves the use of a flexible, illuminated endoscope, which navigates through the digestive tract for direct visualization of critical organs, while simultaneously capturing X-ray images. The ability to provide comprehensive assessments and interventions drives the growth of the ERCP market, catering to the rising needs of healthcare providers worldwide.

Restraints in the Global Endoscopic Retrograde Cholangiopancreatography Market

The growth of the Global Endoscopic Retrograde Cholangiopancreatography market is being restrained by stringent regulatory guidelines enforced by governing bodies in various countries, which create obstacles for the introduction of new technologies. Adhering to these regulations necessitates extensive testing and compliance with safety and efficacy standards, resulting in a complicated and time-consuming approval process for novel medical innovations. Despite these regulatory challenges, there are positive developments within the market. Notably, the increase in disposable income, particularly in developing nations, has emerged as a significant driver of market expansion, indicating potential for future growth despite existing constraints.

Market Trends of the Global Endoscopic Retrograde Cholangiopancreatography Market

The Global Endoscopic Retrograde Cholangiopancreatography (ERCP) market is set to flourish, driven by innovative strategic initiatives from leading industry players. Notable activities, such as product launches, mergers, and acquisitions, are transforming the landscape. For instance, the April 2022 partnership between Olympus and EndoClot Plus, which introduced the EndoClot PHS, exemplifies the market's focus on enhancing therapeutic endoscopic solutions. This collaboration emphasizes the shift towards nonthermal, nontraumatic techniques for efficient hemostasis in gastrointestinal procedures. As healthcare providers increasingly prioritize advanced and effective treatments, the ERCP market is poised for substantial growth, reflecting a commitment to improving patient outcomes and enhancing procedural safety.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies

Global Endoscopic Retrograde Cholangiopancreatography Market Size by Product Type & CAGR (2025-2032)

Market Overview
Endoscopes
Endotherapy Devices
- Sphincterotomes
- Lithotripter
- Stents
- Cannulas
- Forceps
- Snares
- Catheters
- Guiding Wires
- Balloons
- Baskets
Visualization Systems
Energy Devices
Others

Global Endoscopic Retrograde Cholangiopancreatography Market Size by Procedure & CAGR (2025-2032)

Market Overview
Biliary Sphincterotomy
Biliary Stenting
Biliary Dialtation
Pancreatic Sphincterotomy
Pancreatic Duct Stenting
Pancreatic Duct Dilatation

Global Endoscopic Retrograde Cholangiopancreatography Market Size by End Users & CAGR (2025-2032)

Market Overview
Hospitals
Ambulatory Surgery Centers & Clinics
Others

Global Endoscopic Retrograde Cholangiopancreatography Market Size & CAGR (2025-2032)

North America (Product Type, Procedure, End Users)
- US
- Canada
Europe (Product Type, Procedure, End Users)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Procedure, End Users)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Procedure, End Users)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Procedure, End Users)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CONMED Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HOYA Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic PLC (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STERRIS PLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TeleMed Systems Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DCC Healthcare (Medi-Globe GmbH) (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Huger Medical Instrument Co. Ltd (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SonoScape Medical Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KARL STORZ SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ambu A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PENTAX Medical (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hitachi Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Canon Medical Systems Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sony Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

内視鏡的逆行性胆管膵管造影の市場規模、シェア、成長分析、製品タイプ別、手技別、エンドユーザー別、地域別-2025～2032年産業予測

Endoscopic Retrograde Cholangiopancreatography Market Size, Share, and Growth Analysis, By Product Type (Endoscopes, Endotherapy Devices), By Procedure (Biliary Sphincterotomy, Biliary Stenting), By End Users, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と展望

主要市場の考察

内視鏡的逆行性胆管膵管造影市場規模：製品タイプ別&CAGR（2025～2032年）

内視鏡的逆行性胆管膵管造影市場規模：手技別&CAGR（2025～2032年）

内視鏡的逆行性胆管膵管造影市場規模：エンドユーザー別&CAGR（2025～2032年）

内視鏡的逆行性胆管膵管造影市場規模&CAGR（2025～2032年）